Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

RIT2: responsible and susceptible gene for neurological and psychiatric disorders.

Daneshmandpour Y, Darvish H, Emamalizadeh B.

Mol Genet Genomics. 2018 Aug;293(4):785-792. doi: 10.1007/s00438-018-1451-4. Epub 2018 Jun 2. Review.

PMID:
29860660
2.

Association analysis of EIF4G1 and Parkinson disease in Xinjiang Uygur and Han nationality.

Ma Y, Zheng D, Li H.

Medicine (Baltimore). 2018 May;97(18):e0234. doi: 10.1097/MD.0000000000010234.

3.

LRRK2 kinase in Parkinson's disease.

Alessi DR, Sammler E.

Science. 2018 Apr 6;360(6384):36-37. doi: 10.1126/science.aar5683. No abstract available.

PMID:
29622645
4.

MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.

Song Y, Liu Y, Chen X.

Yonsei Med J. 2018 May;59(3):416-424. doi: 10.3349/ymj.2018.59.3.416.

5.

Glial loss of the metallo β-lactamase domain containing protein, SWIP-10, induces age- and glutamate-signaling dependent, dopamine neuron degeneration.

Gibson CL, Balbona JT, Niedzwiecki A, Rodriguez P, Nguyen KCQ, Hall DH, Blakely RD.

PLoS Genet. 2018 Mar 28;14(3):e1007269. doi: 10.1371/journal.pgen.1007269. eCollection 2018 Mar.

6.

Effects of Subthalamic Stimulation on Olfactory Function in Parkinson Disease.

Cury RG, Carvalho MJ, Lasteros FJL, Dias AE, Dos Santos Ghilardi MG, Paiva ARB, Coutinho AM, Buchpiguel CA, Teixeira MJ, Barbosa ER, Fonoff ET.

World Neurosurg. 2018 Jun;114:e559-e564. doi: 10.1016/j.wneu.2018.03.033. Epub 2018 Mar 14.

PMID:
29548954
7.

Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease.

Marrone L, Bus C, Schöndorf D, Fitzgerald JC, Kübler M, Schmid B, Reinhardt P, Reinhardt L, Deleidi M, Levin T, Meixner A, Klink B, Glatza M, Gloeckner CJ, Gasser T, Sterneckert J.

PLoS One. 2018 Mar 7;13(3):e0192497. doi: 10.1371/journal.pone.0192497. eCollection 2018.

8.

Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Jellinger KA, Korczyn AD.

BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.

9.

Parkinson disease related ATP13A2 evolved early in animal evolution.

Sørensen DM, Holemans T, van Veen S, Martin S, Arslan T, Haagendahl IW, Holen HW, Hamouda NN, Eggermont J, Palmgren M, Vangheluwe P.

PLoS One. 2018 Mar 5;13(3):e0193228. doi: 10.1371/journal.pone.0193228. eCollection 2018.

10.

Pharmacological interventions for psychosis in Parkinson's disease patients.

Friedman JH.

Expert Opin Pharmacother. 2018 Apr;19(5):499-505. doi: 10.1080/14656566.2018.1445721. Epub 2018 Mar 1. Review.

PMID:
29494265
11.

Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years.

da Silva FC, Iop RDR, de Oliveira LC, Boll AM, de Alvarenga JGS, Gutierres Filho PJB, de Melo LMAB, Xavier AJ, da Silva R.

PLoS One. 2018 Feb 27;13(2):e0193113. doi: 10.1371/journal.pone.0193113. eCollection 2018. Review.

12.

Acupuncture for management of lower urinary tract symptoms in Parkinson's disease: A protocol for the systematic review of randomized controlled trials.

Kim JI, Choi TY, Jun JH, Kang H, Lee MS.

Medicine (Baltimore). 2018 Feb;97(6):e9821. doi: 10.1097/MD.0000000000009821. Review.

13.

Fatigue in Parkinson's disease: concepts and clinical approach.

Nassif DV, Pereira JS.

Psychogeriatrics. 2018 Mar;18(2):143-150. doi: 10.1111/psyg.12302. Epub 2018 Feb 6. Review.

PMID:
29409156
14.

Depression in Parkinson's disease: A case-control study.

Wu YH, Chen YH, Chang MH, Lin CH.

PLoS One. 2018 Feb 1;13(2):e0192050. doi: 10.1371/journal.pone.0192050. eCollection 2018.

15.

Novel biomolecular information in rotenone-induced cellular model of Parkinson's disease.

Lin D, Liang Y, Zheng D, Chen Y, Jing X, Lei M, Zeng Z, Zhou T, Wu X, Peng S, Huang K, Yang L, Xiao S, Liu J, Tao E.

Gene. 2018 Mar 20;647:244-260. doi: 10.1016/j.gene.2018.01.023. Epub 2018 Jan 10.

PMID:
29331484
16.

Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease.

Song N, Wang J, Jiang H, Xie J.

Biochim Biophys Acta. 2018 Mar;1864(3):967-973. doi: 10.1016/j.bbadis.2018.01.008. Epub 2018 Jan 6. Review.

PMID:
29317336
17.

The analysis of relationship between selected sociodemografic factors and disorders of speech organs in Parkinson`s patients.

Pawlukowska W, Skonieczna-Żydecka K, Rotter I, Honczarenko K, Nowacki P.

BMC Neurol. 2017 Dec 21;17(1):221. doi: 10.1186/s12883-017-1003-2.

18.

Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology.

Fujimoto T, Kuwahara T, Eguchi T, Sakurai M, Komori T, Iwatsubo T.

Biochem Biophys Res Commun. 2018 Jan 8;495(2):1708-1715. doi: 10.1016/j.bbrc.2017.12.024. Epub 2017 Dec 6.

PMID:
29223392
19.

Predictors of Mortality in Nondemented Patients With Parkinson Disease: Motor Symptoms Versus Nonmotor Symptoms.

Santos-García D, Suárez-Castro E, Ernandez J, Expósito-Ruiz I, Tuñas-Gesto C, Aneiros-Díaz M, de Deus-Fonticoba T, López-Fernández M, Núñez-Arias D.

J Geriatr Psychiatry Neurol. 2018 Jan;31(1):19-26. doi: 10.1177/0891988717743589. Epub 2017 Nov 30.

PMID:
29191070
20.

Effects of Commonly Used Pesticides in China on the Mitochondria and Ubiquitin-Proteasome System in Parkinson's Disease.

Chen T, Tan J, Wan Z, Zou Y, Afewerky HK, Zhang Z, Zhang T.

Int J Mol Sci. 2017 Nov 23;18(12). pii: E2507. doi: 10.3390/ijms18122507.

Supplemental Content

Loading ...
Support Center